Evidence map›Paper›PMID 7937827›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America1994

Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol.

M G Traber, R Ramakrishnan, H J Kayden

Registry-linked trialOpen access · bronzeAbstract readClinical TrialControlled Clinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00862433 (Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00862433 phase1completednot on this mapstarted 2014, after this paper: background citation

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2014 to 2022Enrolled50ConditionsDiabetes, Fatty Liver, Obesity, Healthy VolunteersArmsAlpha tocopherol, Vitamin E, Vitamin C
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 156 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Scientific opinion on the tolerable upper intake level for vitamin E.EFSA journal. European Food Safety Authority · 2024
    Article
  9. Review
  10. Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals.Antioxidants (Basel, Switzerland) · 2020
    Review
  11. Article
  12. Review
  13. Complexity of vitamin E metabolism.World journal of biological chemistry · 2016
    Review
  14. Article
  15. Scientific Opinion on Dietary Reference Values for vitamin E as α-tocopherol.EFSA journal. European Food Safety Authority · 2015
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M G TraberDepartment of Medicine, New York University School of Medicine, NY 10016.
R Ramakrishnan
H J Kayden
New York University · USColumbia University · US

Funding

METABOLIC ROLE OF VIT.E: CLINICAL &CELLULAR STUDIESR01HL030842 · NHLBI · NEW YORK UNIVERSITY · PI KAYDEN, HERBERT J · 1985 to 1995
–
NHLBI NIH HHS HL 30842
6 · The paper itself

Abstract

A kinetic model of vitamin E transport in humans is described using data from our studies with deuterium-labeled stereoisomers of alpha-tocopherol (RRR- and SRR-). In normal subjects, both alpha-tocopherols are present at similar concentrations in chylomicrons, but by 24 hr, RRR-alpha-tocopherol is at higher plasma concentrations because RRR-alpha-tocopherol is preferentially incorporated into very low density lipoproteins, which are then secreted into plasma. In three nondiscriminator patients with familial isolated vitamin E deficiency, the fractional disappearance rates (mean +/- SD) of deuterium-labeled RRR- and SRR-alpha-tocopherols in plasma were 1.4 +/- 0.6 and 1.3 +/- 0.3 pools per day, respectively (difference, 0.1 +/- 0.3). In these patients, plasma concentrations of both RRR- and SRR-alpha-tocopherols decreased similarly to SRR-alpha-tocopherol in controls. In six controls, fractional disappearance rates of deuterium-labeled RRR-alpha-tocopherol (0.4 +/- 0.1 pool per day) were significantly (P < 0.01) slower than for SRR- (1.2 +/- 0.6). The differences (0.8 +/- 0.6 pool per day) between these two rates in controls estimate the rate at which RRR-alpha-tocopherol, which had left the plasma, was returned to the plasma. Although plasma labeled RRR-alpha-tocopherol concentrations in controls appear to change slowly, these data show that both RRR- and SRR-alpha-tocopherols leave the plasma rapidly, but only RRR-alpha-tocopherol is returned to the plasma, likely in nascent very low density lipoproteins. This recycling of RRR-alpha-tocopherol accounts for nearly 1 pool of alpha-tocopherol per day.

Indexed as

Administration, OralDeuteriumHumansIntestinal AbsorptionKineticsLiverModels, BiologicalRadioisotope Dilution TechniqueTime FactorsVitamin EDeuteriumVitamin E

Identifiers

PMID7937827
PMCPMC44946
OpenAlexW2058546993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.